LabCorp to Adopt Thermo Fisher Scientific’s Ion Torrent Genexus Next-Generation Sequencing System and Pan-Cancer Assay for Use in Oncology Research and Development

BURLINGTON, N.C. & CARLSBAD, Calif. --(BUSINESS WIRE)--Jan. 14, 2020-- LabCorp® (NYSE: LH) announced it will adopt the Ion Torrent Genexus System* and Oncomine Precision Assay* for use in research and development of companion diagnostics as well as other future oncology and precision medicine

LabCorp to Announce Fourth Quarter and Full Year 2019 Financial Results on February 13, 2020

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- LabCorp® (NYSE: LH) will release its fourth quarter and full year 2019 financial results before the market opens on Thursday, Feb. 13, 2020 , and then will host a conference call and webcast beginning at 9:00 a.m. EDT to discuss the results.

Labcorp and Covance launch extensive preclinical, clinical and post-approval cell and gene therapy development solutions

Specialized Expertise, Coordinated Capabilities and Targeted Investments Designed to Accelerate Development and Reduce Risk for Sponsors BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 13, 2020-- Labcorp® (NYSE:LH), a leading global life sciences company that is deeply integrated in guiding patient care,

LabCorp is Scheduled to Present at the 38th Annual J.P. Morgan Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jan. 6, 2020-- LabCorp® (NYSE: LH) today announced that members of the executive management team will participate in a fireside chat at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14 at 1:30 p.m. (PT) .

Concentration of branched-chain amino acids is a strong risk marker for incident hypertension